Brokerages Anticipate Sabra Health Care REIT Inc (SBRA) Will Post Quarterly Sales of $158.98 Million

Wall Street analysts predict that Sabra Health Care REIT Inc (NASDAQ:SBRA) will announce sales of $158.98 million for the current fiscal quarter, Zacks Investment Research reports. Four analysts have issued estimates for Sabra Health Care REIT’s earnings, with the lowest sales estimate coming in at $154.03 million and the highest estimate coming in at $163.41 million. Sabra Health Care REIT posted sales of $166.47 million during the same quarter last year, which would indicate a negative year-over-year growth rate of 4.5%. The firm is scheduled to report its next earnings results on Wednesday, February 20th.

On average, analysts expect that Sabra Health Care REIT will report full year sales of $649.57 million for the current fiscal year, with estimates ranging from $639.46 million to $659.07 million. For the next financial year, analysts expect that the firm will report sales of $658.59 million, with estimates ranging from $645.70 million to $667.97 million. Zacks’ sales calculations are a mean average based on a survey of analysts that cover Sabra Health Care REIT.

Sabra Health Care REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Monday, November 5th. The real estate investment trust reported $0.20 earnings per share for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.42). The business had revenue of $151.80 million for the quarter, compared to analyst estimates of $162.64 million. Sabra Health Care REIT had a return on equity of 11.80% and a net margin of 61.85%.

SBRA has been the topic of several research reports. Zacks Investment Research downgraded Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research report on Thursday, August 2nd. Mizuho reaffirmed a “buy” rating and issued a $26.00 target price on shares of Sabra Health Care REIT in a research report on Monday, August 13th. ValuEngine raised Sabra Health Care REIT from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 9th. BidaskClub downgraded Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research report on Wednesday, September 26th. Finally, Raymond James upped their target price on Sabra Health Care REIT from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, August 17th. Seven analysts have rated the stock with a hold rating and five have given a buy rating to the company. Sabra Health Care REIT currently has a consensus rating of “Hold” and an average target price of $22.73.

NASDAQ SBRA traded down $0.30 during trading on Monday, reaching $21.39. 2,789,100 shares of the company’s stock were exchanged, compared to its average volume of 1,638,335. The company has a market cap of $3.83 billion, a PE ratio of 8.81, a price-to-earnings-growth ratio of 2.55 and a beta of 0.56. The company has a quick ratio of 3.16, a current ratio of 2.88 and a debt-to-equity ratio of 1.00. Sabra Health Care REIT has a fifty-two week low of $15.77 and a fifty-two week high of $23.83.

The business also recently declared a quarterly dividend, which will be paid on Friday, November 30th. Investors of record on Thursday, November 15th will be given a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 8.42%. The ex-dividend date is Wednesday, November 14th. Sabra Health Care REIT’s dividend payout ratio is currently 74.07%.

Large investors have recently modified their holdings of the stock. Qube Research & Technologies Ltd acquired a new stake in Sabra Health Care REIT during the second quarter worth approximately $115,000. US Bancorp DE grew its position in Sabra Health Care REIT by 91.5% during the second quarter. US Bancorp DE now owns 5,699 shares of the real estate investment trust’s stock worth $124,000 after buying an additional 2,723 shares in the last quarter. NEXT Financial Group Inc acquired a new stake in Sabra Health Care REIT during the third quarter worth approximately $132,000. Centaurus Financial Inc. acquired a new stake in Sabra Health Care REIT during the second quarter worth approximately $125,000. Finally, Winslow Evans & Crocker Inc. acquired a new stake in Sabra Health Care REIT during the third quarter worth approximately $162,000. 90.72% of the stock is currently owned by institutional investors and hedge funds.

About Sabra Health Care REIT

As of June 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 352 Skilled Nursing/Transitional Care facilities, (ii) 89 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 13 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Read More: Stock Symbols and CUSIP Explained

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply